Identification of Autophagy-Related Genes in Patients with Acute Spinal Cord Injury and Analysis of Potential Therapeutic Targets
- 16 August 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (3) , 2674-2694
Abstract
Autophagy has been implicated in the pathogenesis and progression of spinal cord injury (SCI); however, its specific mechanisms remain unclear. This study is aimed at identifying potential molecular biomarkers related to autophagy in SCI through bioinformatics analysis and exploring potential therapeutic targets. The mRNA expression profile dataset GSE151371 was obtained from the GEO database, and R software was used to screen for differentially expressed autophagy-related genes (DE-ARGs) in SCI. A total of 39 DE-ARGs were detected in this study. Enrichment analysis, protein–protein interaction (PPI) network, TF-mRNA-miRNA regulatory network analysis, and the DSigDB database were used to investigate the regulatory mechanisms between DE-ARGs and identify potential drugs for SCI. Enrichment analysis revealed associations with autophagy, apoptosis, and cell death. PPI analysis identified the highest-scoring module and selected 10 hub genes to construct the TF-mRNA-miRNA network, revealing regulatory mechanisms. Analysis of the DSigDB database indicated that 1,9-Pyrazoloanthrone may be a potential therapeutic drug. Machine learning algorithms identified 3 key genes as candidate biomarkers. Additionally, immune cell infiltration results revealed significant correlations between PINK1, NLRC4, VAMP3, and immune cell accumulation. Molecular docking simulations revealed that imatinib can exert relatively strong regulatory effects on the three key proteins. Finally, in vivo experimental data revealed that the overall biological process of autophagy was disrupted. In summary, this study successfully identified 39 DE-ARGs and discovered several promising biomarkers, significantly contributing to our understanding of the underlying mechanisms of autophagy in SCI. These findings offer valuable insights for the development of novel therapeutic strategies.Keywords
Funding Information
- Shaanxi Administration of Traditional Chinese Medicine (2021-04-ZZ-003)
- Key Research and Development Projects of Shaanxi Province (2024SF-YBXM-374)
This publication has 74 references indexed in Scilit:
- Recent advances on signaling pathways and their inhibitors in spinal cord injuryBiomedicine & Pharmacotherapy, 2024
- Crosstalk Between Cell Death and Spinal Cord Injury: Neurology and TherapyMolecular Neurobiology, 2024
- A Novel Magnetic Responsive miR‐26a@SPIONs‐OECs for Spinal Cord Injury: Triggering Neural Regeneration Program and Orienting Axon Guidance in Inhibitory Astrocytic EnvironmentAdvanced Science, 2023
- Identification of the CCL2 PI3K/Akt axis involved in autophagy and apoptosis after spinal cord injuryMetabolic Brain Disease, 2023
- MicroRNA-24-3p Inhibits Microglia Inflammation by Regulating MK2 Following Spinal Cord InjuryNeurochemical Research, 2021
- Bnip3 in mitophagy: Novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunctionClinica Chimica Acta, 2020
- Modern Medical Management of Spinal Cord InjuryCurrent Neurology and Neuroscience Reports, 2019
- Pros and Cons: Autophagy in Acute Spinal Cord InjuryNeuroscience Bulletin, 2019
- Mitophagy Contributes to the Pathogenesis of Inflammatory DiseasesInflammation, 2018
- Inhibition of Autophagy by Estradiol Promotes Locomotor Recovery after Spinal Cord Injury in RatsNeuroscience Bulletin, 2016